Liver Inclusion Appears to Be Protective Against Graft Loss-Due-to Chronic But Not Acute Rejection Following Intestinal Transplantation
Transplant International · 14.09.2023 · 36
DOI: 10.3389/ti.2023.11568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, online erschienen am 14.09.2023. Verfasst von Rodrigo Vianna und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Miami Transplant Institute, Miller School of Medicine, University of Miami, Miami, FL, United States. Hauptthemen laut MEDLINE: Liver Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In intestinal transplantation, while other centers have shown that liver-including allografts have significantly more favorable graft survival and graft loss-due-to chronic rejection (CHR) rates, our center has consistently shown that modified multivisceral (MMV) and full multivisceral (MV) allografts have significantly more favorable acute cellular rejection (ACR) and severe ACR rates compared with isolated intestine (I) and liver-intestine (LI) allografts. In the attempt to resolve this apparent discrepancy, we performed stepwise Cox multivariable analyses of the hazard rates of developing graft loss-due-to acute rejection (AR) vs. CHR among 350 consecutive intestinal transplants at our center with long-term follow-up (median: 13.5 years post-transplant). Observed percentages developing graft loss-due-to AR and CHR were 14.3% (50/350) and 6.6% (23/350), respectively. Only one baseline variable was selected into the Cox model indicating a significantly lower hazard rate of developing graft loss-due-to AR: Transplant Type MMV or MV ( p < 0.000001). Conversely, two baseline variables were selected into the Cox model indicating a significantly lower hazard rate of developing graft loss-due-to CHR: Received Donor Liver (LI or MV) ( p = 0.002) and Received Induction ( p = 0.007). In summary, while MMV/MV transplants (who receive extensive native lymphoid tissue removal) offered protection against graft loss-due-to AR, liver-containing grafts appeared to offer protection against graft loss-due-to CHR, supporting the results of other studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Miami Transplant Institute, Miller School of Medicine, University of Miami, Miami, FL, United States.
- Department of Surgery, Zagazig University School of Medicine, Zagazig, Egypt.
- Department of Pediatrics, Miami Transplant Institute, Miller School of Medicine, University of Miami, Miami, FL, United States.
Zitieren
APA
Vianna, R., Gaynor, J. J., Selvaggi, G., Farag, A., Garcia, J., Tekin, A., Tabbara, M. M., & Ciancio, G. (2023). Liver Inclusion Appears to Be Protective Against Graft Loss-Due-to Chronic But Not Acute Rejection Following Intestinal Transplantation. Transplant International, 36. https://doi.org/10.3389/ti.2023.11568
Vancouver
Vianna R, Gaynor JJ, Selvaggi G, Farag A, Garcia J, Tekin A, et al. Liver Inclusion Appears to Be Protective Against Graft Loss-Due-to Chronic But Not Acute Rejection Following Intestinal Transplantation. Transplant International. 2023;36. doi:10.3389/ti.2023.11568
BibTeX
@article{Vianna2023,
author = {Vianna, Rodrigo and Gaynor, Jeffrey J and Selvaggi, Gennaro and Farag, Ahmed and Garcia, Jennifer and Tekin, Akin and Tabbara, Marina M and Ciancio, Gaetano},
title = {Liver Inclusion Appears to Be Protective Against Graft Loss-Due-to Chronic But Not Acute Rejection Following Intestinal Transplantation},
journal = {Transplant International},
year = {2023},
volume = {36},
doi = {10.3389/ti.2023.11568}
}
EUVIMED